Market Overview:
The global insulin drug delivery devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in insulin drug delivery devices, and rising demand for minimally invasive procedures. Based on type, the global insulin drug delivery devices market is segmented into syringes, insulin pens, jet injectors, and insulin pumps. The syringes segment is expected to dominate the market during the forecast period owing to their low cost and easy availability. However, the insulin pump segment is projected to grow at a higher CAGR due its advantages such as accuracy and convenience over other types of devices. Based on application, hospitals are estimated to account for the largest share of the global insulin drug delivery devices market in 2018 followed by clinics and homecare settings. Rising geriatric population coupled with increasing incidence of diabetes are some key factors that are driving demand for these devices in hospitals globally.
Product Definition:
Insulin drug delivery devices are used to inject insulin into the body. They come in a variety of forms, including pens, syringes, and pumps. These devices allow people with diabetes to easily and accurately inject insulin into their bodies. The importance of insulin drug delivery devices is that they make it easy for people with diabetes to get the medication they need to control their blood sugar levels.
Syringes:
Insulin delivery devices are the medical devices used to deliver insulin to diabetic patients. Insulin pen, jet injector, and lancets are some of the common types of insulin delivery devices. The market for syringes is expected to grow at a lucrative rate during the forecast period owing to factors such as increasing prevalence of diabetes and awareness about its treatment among people.
Insulin Pens:
Insulin pens are devices that are used to deliver insulin through injection. They work on the principal of pressure-sensitive adhesive which allows for easy and quick application of insulin with a press of a button. Insulin pens have been designed to replace manual injections thus improving the quality of life for diabetic patients by reducing pain, anxiety, and stress associated with conventional methods of delivering an injection.
The global insulin pens.
Application Insights:
The others application segment includes research institutes, homecare and self-administration. The global insulin drug delivery devices market in the others segment was valued at USD 544.0 million in 2017 owing to increasing product use for treating type 1 and other diabetes mellitus patients as well as for diabetic ketoacidosis (DKA). Furthermore, growing awareness about these devices is expected to fuel their demand over the forecast period.
Type 1 diabetes dominated the overall industry with a revenue share of around 60% in 2017 due to high usage rates of insulin pumps among this population group. Increasing adoption of these products through various funding programs such as U.S.-based JDRF International Program on Type 1 Diabetes (IPT1) is expected to drive growth over the forecast period which ends on 2030 when IPT1 ends its funding program.
Regional Analysis:
North America dominated the global insulin drug delivery devices market in 2017. This can be attributed to the presence of a large patient base, technological advancements, and high healthcare expenditure in this region. Moreover, increasing cases of diabetes are also one of the major factors responsible for its largest share.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising disposable income and improving economic conditions especially after China’s entry into World Trade Organization (WTO). Furthermore growing medical tourism industry due low treatment cost coupled with availability of skilled professionals will boost demand further over next eight years.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for insulin drug delivery devices in the coming years.
- Technological advancements: The development of novel and advanced insulin drug delivery devices is expected to fuel the growth of this market in the near future.
- Growing awareness about diabetes and its treatment options: There has been a growing awareness about diabetes and its treatment options among people across the globe in recent years. This is likely to boost demand for insulin drug delivery devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Insulin Drug Delivery Devices Market Research Report
By Type
Syringes, Insulin Pens, Jet Injectors, Insulin Pumps
By Application
Hospitals, Clinics, Homecare, Others
By Companies
Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Dance Biopharm, Roche, Tandem Diabetes Care, Animas
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Insulin Drug Delivery Devices Market Report Segments:
The global Insulin Drug Delivery Devices market is segmented on the basis of:
Types
Syringes, Insulin Pens, Jet Injectors, Insulin Pumps
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Homecare, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk
- Sanofi
- BD
- Eli Lilly
- Medtronic
- Beta Bionics
- Dance Biopharm
- Roche
- Tandem Diabetes Care
- Animas
Highlights of The Insulin Drug Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Syringes
- Insulin Pens
- Jet Injectors
- Insulin Pumps
- By Application:
- Hospitals
- Clinics
- Homecare
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Insulin Drug Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Insulin drug delivery devices are medical devices that help to administer insulin safely and effectively. They can be pens, injections, or pumps.
Some of the major companies in the insulin drug delivery devices market are Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Dance Biopharm, Roche, Tandem Diabetes Care, Animas.
The insulin drug delivery devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Insulin Drug Delivery Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Insulin Drug Delivery Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Insulin Drug Delivery Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Insulin Drug Delivery Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Insulin Drug Delivery Devices Market Size & Forecast, 2020-2028
4.5.1 Insulin Drug Delivery Devices Market Size and Y-o-Y Growth
4.5.2 Insulin Drug Delivery Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Syringes
5.2.2 Insulin Pens
5.2.3 Jet Injectors
5.2.4 Insulin Pumps
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Homecare
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Insulin Drug Delivery Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Insulin Drug Delivery Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Syringes
9.6.2 Insulin Pens
9.6.3 Jet Injectors
9.6.4 Insulin Pumps
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Homecare
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Syringes
10.6.2 Insulin Pens
10.6.3 Jet Injectors
10.6.4 Insulin Pumps
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Homecare
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Syringes
11.6.2 Insulin Pens
11.6.3 Jet Injectors
11.6.4 Insulin Pumps
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Homecare
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Syringes
12.6.2 Insulin Pens
12.6.3 Jet Injectors
12.6.4 Insulin Pumps
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Homecare
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Syringes
13.6.2 Insulin Pens
13.6.3 Jet Injectors
13.6.4 Insulin Pumps
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Homecare
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Insulin Drug Delivery Devices Market: Competitive Dashboard
14.2 Global Insulin Drug Delivery Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novo Nordisk
14.3.2 Sanofi
14.3.3 BD
14.3.4 Eli Lilly
14.3.5 Medtronic
14.3.6 Beta Bionics
14.3.7 Dance Biopharm
14.3.8 Roche
14.3.9 Tandem Diabetes Care
14.3.10 Animas
